A detailed history of Ims Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Ims Capital Management holds 279 shares of LLY stock, worth $221,902. This represents 0.12% of its overall portfolio holdings.

Number of Shares
279
Previous 279 -0.0%
Holding current value
$221,902
Previous $217,000 16.13%
% of portfolio
0.12%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 12, 2024

BUY
$592.2 - $792.28 $165,223 - $221,046
279 New
279 $217,000
Q2 2020

Jul 15, 2020

SELL
$136.42 - $164.18 $210,223 - $253,001
-1,541 Closed
0 $0
Q1 2020

Apr 03, 2020

BUY
$119.05 - $147.35 $183,456 - $227,066
1,541 New
1,541 $214,000
Q4 2018

Feb 07, 2019

SELL
$105.9 - $118.64 $12,708 - $14,236
-120 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $10,303 - $12,877
120 New
120 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ims Capital Management Portfolio

Follow Ims Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ims Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Ims Capital Management with notifications on news.